HomeEPRX • NASDAQ
add
Eupraxia Pharmaceuticals Inc
Previous close
$3.76
Day range
$3.67 - $3.87
Year range
$2.22 - $4.48
Market cap
188.57M CAD
Avg Volume
13.82K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.12M | 6.44% |
Net income | -6.76M | -11.91% |
Net profit margin | — | — |
Earnings per share | -0.29 | -0.39% |
EBITDA | -7.10M | -6.40% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 27.45M | -23.54% |
Total assets | 29.23M | -20.21% |
Total liabilities | 2.20M | -88.13% |
Total equity | 27.03M | — |
Shares outstanding | 35.85M | — |
Price to book | -41.78 | — |
Return on assets | -55.51% | — |
Return on capital | -60.38% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.76M | -11.91% |
Cash from operations | -6.00M | 2.18% |
Cash from investing | -169.04K | -2,389.97% |
Cash from financing | 429.92K | -98.14% |
Net change in cash | -5.65M | -134.09% |
Free cash flow | -3.78M | 3.93% |
About
Founded
2011
Headquarters
Website
Employees
33
